Keyphrases
Combination Chemotherapy
100%
Malignant Melanoma
100%
Triple Combination
75%
Carboxamide
75%
Imidazole
75%
Hepatic Metastasis
75%
Merkel Cell Carcinoma
50%
Median Survival
50%
Pulmonary Metastasis
50%
Lymph Node Metastasis
50%
Chemotherapy
50%
5-fluorouracil (5-FU)
50%
Lactic Dehydrogenase
50%
Seminoma
50%
Disseminated Melanoma
50%
Duration of Response
50%
Complete Response
50%
Gastrointestinal Neoplasms
50%
From the Editor
41%
Combined Method
25%
Response Rate
25%
Osseous
25%
Dosage Regimen
25%
Measurable Disease
25%
Disseminated Metastasis
25%
Systemic Metastasis
25%
Surgical Approach
25%
Complete Remission
25%
Metastatic Disease
25%
Non-responders
25%
CNS Metastases
25%
Cytotoxic Chemotherapy
25%
Route of Administration
25%
Sinai
25%
Therapeutic Approaches
25%
Drug Dosage
25%
High Incidence
25%
Weekly Administration
25%
Package Insert
25%
Medical Center
25%
Oral Route
25%
Differential Diagnosis
16%
Metastatic Seminoma
16%
Malignant Lymphoma
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Melanoma
100%
Carmustine
83%
Imidazolecarboxamide
66%
Liver Metastasis
66%
Vincristine
66%
Fluorouracil
50%
Gastrointestinal Tumor
50%
Disease
41%
Lymph Node Metastasis
41%
Lung Metastasis
41%
Metastasis
25%
Neoplasm
25%
Recurrent Disease
25%
Medicine and Dentistry
Metastatic Carcinoma
75%
Cancer Cell
50%
Lactate Dehydrogenase
50%
Merkel Cell
50%
Gastrointestinal Tumor
50%
Fluorouracil
50%
Seminoma
50%
Chemotherapy
50%
Neoplasm
25%
Cytotoxic Chemotherapy
25%
Surgical Approach
25%
Drug Dose Regimen
25%
Differential Diagnosis
16%
Lymphoma
16%